|
1
|
Bastian BC: The molecular pathology of
melanoma: An integrated taxonomy of melanocytic neoplasia. Annu Rev
Pathol. 9:239–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wahid M, Jawed A, Mandal RK, Dar SA,
Akhter N, Somvanshi P, Khan F, Lohani M, Areeshi MY and Haque S:
Recent developments and obstacles in the treatment of melanoma with
BRAF and MEK inhibitors. Crit Rev Oncol Hematol. 125:84–88. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ankeny JS, Labadie B, Luke J, Hsueh E,
Messina J and Zager JS: Review of diagnostic, prognostic, and
predictive biomarkers in melanoma. Clin Exp Metastasis. 35:487–493.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Corrie PG, Marshall A, Dunn JA, Middleton
MR, Nathan PD, Gore M, Davidson N, Nicholson S, Kelly CG, Marples
M, et al: Adjuvant bevacizumab in patients with melanoma at high
risk of recurrence (AVAST-M): Preplanned interim results from a
multicentre, open-label, randomised controlled phase 3 study.
Lancet Oncol. 15:620–630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ichihashi N and Kitajima Y: Chemotherapy
induces or increases expression of multidrug resistance-associated
protein in malignant melanoma cells. Br J Dermatol. 144:745–750.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li S, Wu Z, Ma P, Xu Y, Chen Y, Wang H, He
P, Kang Z, Yin L, Zhao Y, et al: Ligand-dependent EphA7 signaling
inhibits prostate tumor growth and progression. Cell Death Dis.
8:e31222017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Holland SJ, Gale NW, Gish GD, Roth RA,
Songyang Z, Cantley LC, Henkemeyer M, Yancopoulos GD and Pawson T:
Juxtamembrane tyrosine residues couple the Eph family receptor
EphB2/Nuk to specific SH2 domain proteins in neuronal cells. EMBO
J. 16:3877–3888. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Kataoka H, Suzuki M, Sato N,
Nakamura R, Tao H, Maruyama K, Isogaki J, Kanaoka S, Ihara M, et
al: Downregulation of EphA7 by hypermethylation in colorectal
cancer. Oncogene. 24:5637–5647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang LF, Fokas E, Juricko J, You A, Rose
F, Pagenstecher A, Engenhart-Cabillic R and An HX: Increased
expression of EphA7 correlates with adverse outcome in primary and
recurrent glioblastoma multiforme patients. BMC Cancer. 8:792008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia J, Jia P, Hutchinson KE, Dahlman KB,
Johnson D, Sosman J, Pao W and Zhao Z: A meta-analysis of somatic
mutations from next generation sequencing of 241 melanomas: A road
map for the study of genes with potential clinical relevance. Mol
Cancer Ther. 13:1918–198. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Qiu C, Tu J, Geng B, Yang J, Jiang T
and Cui Q: HMDD v2.0: A database for experimentally supported human
microRNA and disease associations. Nucleic Acids Res. 42((Database
Issue)): D1070–D1074. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Valastyan S, Reinhardt F, Benaich N,
Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL and
Weinberg RA: Retraction notice to: A pleiotropically acting
microRNA, miR-31, inhibits breast cancer metastasis. Cell.
161:4172015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu M, Zhou K and Cao Y: MicroRNA-944
affects cell growth by targeting EPHA7 in non-small cell lung
cancer. Int J Mol Sci. 17:14932016. View Article : Google Scholar
|
|
16
|
Penna E, Orso F, Cimino D, Tenaglia E,
Lembo A, Quaglino E, Poliseno L, Haimovic A, Osella-Abate S, De
Pittà C, et al: microRNA-214 contributes to melanoma tumour
progression through suppression of TFAP2C. EMBO J. 30:1990–2007.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stark MS, Klein K, Weide B, Haydu LE,
Pflugfelder A, Tang YH, Palmer JM, Whiteman DC, Scolyer RA, Mann
GJ, et al: The prognostic and predictive value of melanoma-related
MicroRNAs using tissue and serum: A MicroRNA expression analysis.
EBioMedicine. 2:671–680. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen X, Wu L, Li D, Xu Y, Zhang L, Niu K,
Kong R, Gu J, Xu Z, Chen Z and Sun J: Radiosensitizing effects of
miR-18a-5p on lung cancer stem-like cells via downregulating both
ATM and HIF-1α. Cancer Med. 7:3834–3847. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang C, Zhang X, Wang HM, Liu XM, Zhang
XJ, Zheng B, Qian GR and Ma ZL: MicroRNA-18a-5p functions as an
oncogene by directly targeting IRF2 in lung cancer. Cell Death Dis.
8:e27642017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Linck L, Liebig J, Völler D, Eichner N,
Lehmann G, Meister G and Bosserhoff A: MicroRNA-sequencing data
analyzing melanoma development and progression. Exp Mol Pathol.
105:371–379. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
World Medical Association: World medical
association declaration of Helsinki: Ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak JK and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dawson MA and Kouzarides T: Cancer
epigenetics: From mechanism to therapy. Cell. 150:12–27. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kita Y, Yonemori K, Osako Y, Baba K, Mori
S, Maemura K and Natsugoe S: Noncoding RNA and colorectal cancer:
Its epigenetic role. J Hum Genet. 62:41–47. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Calvano Filho CM, Calvano-Mendes DC,
Carvalho KC, Maciel GA, Ricci MD, Torres AP, Filassi JR and Baracat
EC: Triple-negative and luminal A breast tumors: Differential
expression of miR-18a-5p, miR-17-5p, and miR-20a-5p. Tumour Biol.
35:7733–7741. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang N, Zhang H, Liu Y, Su P, Zhang J,
Wang X, Sun M, Chen B, Zhao W, Wang L, et al: SREBP1, targeted by
miR-18a-5p, modulates epithelial-mesenchymal transition in breast
cancer via forming a co-repressor complex with Snail and HDAC1/2.
Cell Death Differ. 26:843–859. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang G, Han G, Zhang X, Yu Q, Li Z, Li Z
and Li J: Long non-coding RNA FENDRR reduces prostate cancer
malignancy by competitively binding miR-18a-5p with RUNX1.
Biomarkers. 23:435–445. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Burgess JT, Bolderson E, Adams MN, Baird
AM, Zhang SD, Gately KA, Umezawa K, O'Byrne KJ and Richard DJ:
Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic
response. Cell Death Dis. 7:e24692016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guan M, Xu C, Zhang F and Ye C: Aberrant
methylation of EphA7 in human prostate cancer and its relation to
clinicopathologic features. Int J Cancer. 124:88–94. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Oricchio E and Wendel HG: Mining the
cancer genome uncovers therapeutic activity of EphA7 against
lymphoma. Cell Cycle. 11:1076–1080. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Li G, Ma H, Bao Y, Wang X, Zhou H,
Sheng Z, Sugimura H, Jin J and Zhou X: Differential expression of
EphA7 receptor tyrosine kinase in gastric carcinoma. Hum Pathol.
38:1649–1656. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li MY, Zhu XL, Zhao BX, Shi L, Wang W, Hu
W, Qin SL, Chen BH, Zhou PH, Qiu B, et al: Adrenomedullin
alleviates the pyroptosis of leydig cells by promoting autophagy
via the ROS-AMPK-mTOR axis. Cell Death Dis. 10:4892019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Komatsu M and Ichimura Y: Physiological
significance of selective degradation of p62 by autophagy. FEBS
Lett. 584:1374–1378. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mathew R, Karp CM, Beaudoin B, Vuong N,
Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, et al:
Autophagy suppresses tumorigenesis through elimination of p62.
Cell. 137:1062–1075. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li Z, Jiang K, Zhu X, Lin G, Song F, Zhao
Y, Piao Y, Liu J, Cheng W, Bi X, et al: Encorafenib (LGX818), a
potent BRAF inhibitor, induces senescence accompanied by autophagy
in BRAFV600E melanoma cells. Cancer Lett. 370:332–344. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Meng XX, Yao M, Zhang XD, Xu HX and Dong
Q: ER stress-induced autophagy in melanoma. Clin Exp Pharmacol
Physiol. 42:811–816. 2015. View Article : Google Scholar : PubMed/NCBI
|
